| multi- | Many, properly joined only to words of L. Derivation. See: pluri-. Compare: poly-. Origin: L. Multus, much (05 Mar 2000) |
|---|---|
| multi-colony-stimulating factor | <cytokine> Product of mitogen activated T-cells: colony-stimulating factor for bone marrow stem cells and mast cells. A multilineage cell growth factor secreted by lymphocytes, epithelial cells, and astrocytes which stimulates clonal proliferation and differentiation of various types of blood and tissue cells. It is considered one of the haematopoietic colony-stimulating factors. Synonym: multi-CSF Acronym: IL-3 (12 Dec 1998) |
| multi-CSF | <abbreviation> Multi-colony-stimulating factor. (05 Mar 2000) |
| multi-infarct dementia | <neurology> This form of dementia is caused by a number of strokes in the brain. These strokes can cause specific symptoms, depending on their severity and location and can cause general symptoms of dementia. MID cannot be treated, once the nerve cells die, they cannot be replaced. However, the underlying condition leading to strokes (for example, high blood pressure, diabetes) can be treated, which may help prevent further damage. Synonym: vascular dementia. (22 May 1997) |
| multi-infection | Mixed infection with two or more varieties of microorganisms developing simultaneously. (05 Mar 2000) |
| multi-institutional systems | Institutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures. (12 Dec 1998) |
| multi locus enzyme electrophoresis | Inhibition of translation of the transcript of a transposase gene by a multicopy plasmid with suitable inhibitory gene. The plasmid inhibits transposition events in the host bacterium. (18 Nov 1997) |
| multi-locus probe | A probe that hybridizes to anumber of different sites in the genome of an organism. (09 Oct 1997) |
| dementia, multi-infarct | Organic mental disorder caused by repetitive multiple cerebral infarcts which act cumulatively to produce dementia. Vascular disease is always presumed to be present. (12 Dec 1998) |
| adrenergic blocking agent | A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's. (05 Mar 2000) |
| adrenergic neuronal blocking agent | A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines. (05 Mar 2000) |
| agent | <pharmacology> Any power, principle or substance capable of producing an effect, whether physical, chemical or biological. Origin: L. Agens = acting (18 Nov 1997) |
| agent, antihypertensive | As the name suggests, a drug aimed at reducing high blood pressure (hypertension). (12 Dec 1998) |
| agent, anti-infective | Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. (12 Dec 1998) |
| Agent Orange | An herbicide and defoliant, consisting of (2,4,5-trichlorophenoxy)acetic acid, (2,4-dichlorophenoxy)acetic acid, and dioxin, that was widely used in the Vietnam War; it has been shown to possess residual post-exposure carcinogenic and teratogenic properties in humans. (05 Mar 2000) |